1、注意:tab改為21pt,中文第一行有縮排,英文第一行無縮排。注意:tab改為21pt,中文第一行有縮排,英文第一行無縮排。注意:tab改為21pt,中文第一行有縮排,英文第一行無縮排。注意:tab改為21pt,中文第一行有縮排,英文第一行無縮排。CONTENTS02Corporate Information04Management Discussion and Analysis19Corporate Governance and Additional InformationUnaudited Interim Financial Information33Independent Review
2、Report35Interim Condensed Consolidated Statement of Profit or Loss36Interim Condensed Consolidated Statement of Comprehensive Income37Interim Condensed Consolidated Statement of Financial Position39Interim Condensed Consolidated Statement of Changes in Equity41Interim Condensed Consolidated Statemen
3、t of Cash Flows44Notes to the Interim Condensed Consolidated Financial Information注意:tab改為21pt,中文第一行有縮排,英文第一行無縮排。02ALIBABA HEALTH Information Technology Limited 2025 Interim ReportCORPORATE INFORMATIONBOARD OF DIRECTORS Executive DirectorsMr.ZHU Shunyan(Chairman)(re-designated to a non-executive Dir
4、ector with effect from September 1,2024)Mr.SHEN Difan(Chief Executive Officer)Mr.TU YanwuNon-executive DirectorsMr.ZHU Shunyan(Chairman)(re-designated as a non-executive Director with effect from September 1,2024)Ms.HUANG JiaojiaoMr.XU HaipengIndependent Non-executive DirectorsMs.HUANG Yi Fei(Vaness
5、a)Dr.SHAO RongMs.WU May YihongAudit CommitteeMs.WU May Yihong(Chairman)Ms.HUANG Yi Fei(Vanessa)Dr.SHAO RongRemuneration CommitteeMs.HUANG Yi Fei(Vanessa)(Chairman)Ms.HUANG JiaojiaoMs.WU May YihongNomination CommitteeMr.ZHU Shunyan(Chairman)Dr.SHAO RongMs.WU May YihongAUTHORIZED REPRESENTATIVESMr.SHE
6、N DifanMs.TSUI Hiu LeongCOMPANY SECRETARIESMs.TSUI Hiu LeongMs.DENG YanLEGAL ADVISORFangda PartnersAUDITORErnst&YoungCertified Public AccountantsRegistered Public Interest Entity AuditorREGISTERED OFFICEVictoria Place5th Floor31 Victoria StreetHamilton HM 10BermudaPRINCIPAL PLACE OF BUSINESS IN HONG